Business Description
Diamond Biotechnology Co Ltd
ISIN : TW0006815004
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.72 | |||||
Equity-to-Asset | 0.59 | |||||
Debt-to-Equity | 0.51 | |||||
Debt-to-EBITDA | 2.33 | |||||
Interest Coverage | 12.57 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 4.69 | |||||
Beneish M-Score | -2.42 | |||||
WACC vs ROIC |
Growth Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 24.8 | |||||
3-Year EBITDA Growth Rate | 16.7 | |||||
3-Year EPS without NRI Growth Rate | 68.6 | |||||
3-Year Book Growth Rate | 14.3 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 40.2 | |||||
9-Day RSI | 47.75 | |||||
14-Day RSI | 50.26 | |||||
6-1 Month Momentum % | -35.11 | |||||
12-1 Month Momentum % | -11.63 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.9 | |||||
Quick Ratio | 2.53 | |||||
Cash Ratio | 0.97 | |||||
Days Inventory | 78.67 | |||||
Days Sales Outstanding | 104.73 | |||||
Days Payable | 33.77 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.22 | |||||
Dividend Payout Ratio | 0.05 | |||||
Forward Dividend Yield % | 0.22 | |||||
5-Year Yield-on-Cost % | 0.22 | |||||
Shareholder Yield % | -10.51 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 47.37 | |||||
Operating Margin % | 14.47 | |||||
Net Margin % | 9.47 | |||||
FCF Margin % | -7.79 | |||||
ROE % | 15.59 | |||||
ROA % | 7.67 | |||||
ROIC % | 12.33 | |||||
3-Year ROIIC % | 13.62 | |||||
ROC (Joel Greenblatt) % | 15.22 | |||||
ROCE % | 14.92 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 34.93 | |||||
PE Ratio without NRI | 33.46 | |||||
PEG Ratio | 25.74 | |||||
PS Ratio | 3.31 | |||||
PB Ratio | 4.1 | |||||
Price-to-Tangible-Book | 4.13 | |||||
EV-to-EBIT | 28.18 | |||||
EV-to-EBITDA | 19.56 | |||||
EV-to-Revenue | 3.67 | |||||
EV-to-FCF | -47.54 | |||||
Price-to-Graham-Number | 2.48 | |||||
Price-to-Net-Current-Asset-Value | 10.28 | |||||
Earnings Yield (Greenblatt) % | 3.55 | |||||
FCF Yield % | -2.19 | |||||
Forward Rate of Return (Yacktman) % | 0.98 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Diamond Biotechnology Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil NT$) | 707.536 | ||
EPS (TTM) (NT$) | 2.127 | ||
Beta | 0.8 | ||
Volatility % | 24.24 | ||
14-Day RSI | 50.26 | ||
14-Day ATR (NT$) | 4.173839 | ||
20-Day SMA (NT$) | 74.965 | ||
12-1 Month Momentum % | -11.63 | ||
52-Week Range (NT$) | 59 - 113.94803 | ||
Shares Outstanding (Mil) | 33.79 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 7 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Diamond Biotechnology Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Diamond Biotechnology Co Ltd Stock Events
Event | Date | Price(NT$) | ||
---|---|---|---|---|
No Event Data |
Diamond Biotechnology Co Ltd Frequently Asked Questions
What is Diamond Biotechnology Co Ltd(ROCO:6815)'s stock price today?
When is next earnings date of Diamond Biotechnology Co Ltd(ROCO:6815)?
Does Diamond Biotechnology Co Ltd(ROCO:6815) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |